Your browser doesn't support javascript.
loading
Safety and immunogenicity of three doses of non-typeable Haemophilus influenzae-Moraxella catarrhalis (NTHi-Mcat) vaccine when administered according to two different schedules: a phase 2, randomised, observer-blind study.
Galgani, Ilaria; Annaratone, Margherita; Casula, Daniela; Di Maro, Gennaro; Janssens, Michel; Tasciotti, Annaelisa; Schwarz, Tino; Ferguson, Murdo; Arora, Ashwani Kumar.
Affiliation
  • Galgani I; GSK, Siena, Italy. ilaria.x.galgani@gsk.com.
  • Annaratone M; GSK, Siena, Italy.
  • Casula D; GSK, Siena, Italy.
  • Di Maro G; GSK, Siena, Italy.
  • Janssens M; GSK, Rixensart, Belgium.
  • Tasciotti A; GSK, Siena, Italy.
  • Schwarz T; Institute of Laboratory Medicine and Vaccination Centre, Klinikum Würzburg Mitte, Campus Juliusspital, Würzburg, Germany.
  • Ferguson M; Colchester Research Group, Truro, Canada.
  • Arora AK; GSK, Siena, Italy.
Respir Res ; 23(1): 114, 2022 May 04.
Article in En | MEDLINE | ID: mdl-35509077
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccines / Pulmonary Disease, Chronic Obstructive / Gout Type of study: Clinical_trials / Prognostic_studies Limits: Aged / Humans Language: En Journal: Respir Res Year: 2022 Type: Article Affiliation country: Italy
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccines / Pulmonary Disease, Chronic Obstructive / Gout Type of study: Clinical_trials / Prognostic_studies Limits: Aged / Humans Language: En Journal: Respir Res Year: 2022 Type: Article Affiliation country: Italy